Table 1 Baseline Characteristics
Characteristic | IM (n = 998) | VLM (n = 441) | P-value |
|---|---|---|---|
Age (IQR yrs) | 36.2 (31.5 – 41.3) | 35 (30 – 41) | 0.002 |
Gender | 0.667 | ||
Female | 680 (68%) | 306 (69%) | |
Male | 318 (32%) | 135 (31%) | |
Baseline CD4 (IQR cells/μl) | 86 (29–154) | 101.5 (30.5-170) | 0.330 |
WHO Stage | (n = 996) | <0.0001 | |
WHO Stage I | 18 (2%) | 2 (1%) | |
WHO Stage II | 233 (23%) | 49 (11%) | |
WHO Stage III | 478 (48%) | 257 (58%) | |
WHO Stage IV | 267 (27%) | 133 (30%) | |
Hb (IQR) | 11.3 (10.0 – 12.7) | 11.7 (10.6 – 13.0) | 0.001 |
BMI (IQR kg/m2) | 20.2 (18.2 – 22.5) | 20.2 (18.3 – 22.6) | 0.917 |
ART Regimen | 0.726 | ||
d4T/3TC/NVP | 721 (72%) | 325 (74%) | |
d4T/3TC/EFV | 3 (0.5%) | 0 | |
ZDV/3TC/NVP | 2 (0.5%) | 0 | |
ZDV/3TC/EFV | 272 (27%) | 116 (26%) |